# RELMADA THERAPEUTICS, INC. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:025d90a8-f941-4960-9a33-3393bec9d167 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/relmada-therapeutics-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 24 | | Claims under review | 1 | | Evidence records | 7 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-10T04:46:27.563543+00:00 | | Last reviewed | 2026-10-10T04:46:27.563543+00:00 | ## Identity - Legal name: RELMADA THERAPEUTICS, INC. - Display name: RELMADA THERAPEUTICS, INC. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-10T07:12:01.057708+00:00 | | Completeness | 0.409 | | Record Quality | 0.832 | | Directors | 4 | | Committees | 6 | | Governance events | 14 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Charles J. Casamento: Director. Status: current. Independent: true. Since: 2015-01-01. Committees: Audit (member); Audit; Compensation; Nominating and Governance (member); Compensation (member); Nominating and Governance (member). claim_id=alpha:claim:company:025d90a8-f941-4960-9a33-3393bec9d167:leadership_role:5 - Fabiana Fedeli: Director. Status: current. Independent: true. Since: 2023-01-01. Committees: Audit (chair); Audit · Chair; Compensation; Nominating and Governance (member); Compensation (member); Nominating and Governance (member). claim_id=alpha:claim:company:025d90a8-f941-4960-9a33-3393bec9d167:leadership_role:6 - John Glasspool: Director. Status: current. Independent: true. Since: 2019-01-01. Committees: Audit (member); Audit; Compensation; Nominating and Governance · Chair (member); Compensation (member); Nominating and Governance (chair). claim_id=alpha:claim:company:025d90a8-f941-4960-9a33-3393bec9d167:leadership_role:7 - Sergio Traversa: Director. Status: current. Independent: false. Since: 2012-01-01. claim_id=alpha:claim:company:025d90a8-f941-4960-9a33-3393bec9d167:leadership_role:8 ## Committees - Audit (audit). Chair: Fabiana Fedeli. Members: Fabiana Fedeli (chair, current); Charles J. Casamento (member, current); John Glasspool (member, current); Fabiana Fedeli (chair, unknown); Charles J. Casamento (member, unknown); John Glasspool (member, unknown). committee_id=alpha:committee:relmada-therapeutics-inc:audit - Audit · Chair; Compensation; Nominating and Governance (audit). Chair: NOT_PUBLISHED. Members: Fabiana Fedeli (member, current). committee_id=alpha:committee:relmada-therapeutics-inc:audit-chair-compensation-nominating-and-governance - Audit; Compensation; Nominating and Governance (audit). Chair: NOT_PUBLISHED. Members: Charles J. Casamento (member, current). committee_id=alpha:committee:relmada-therapeutics-inc:audit-compensation-nominating-and-governance - Audit; Compensation; Nominating and Governance · Chair (audit). Chair: NOT_PUBLISHED. Members: John Glasspool (member, current). committee_id=alpha:committee:relmada-therapeutics-inc:audit-compensation-nominating-and-governance-chair - Compensation (compensation). Chair: NOT_PUBLISHED. Members: Charles J. Casamento (member, current); Fabiana Fedeli (member, current); John Glasspool (member, current); Charles J. Casamento (member, unknown); Fabiana Fedeli (member, unknown); John Glasspool (member, unknown). committee_id=alpha:committee:relmada-therapeutics-inc:compensation - Nominating and Governance (nominating_governance). Chair: John Glasspool. Members: John Glasspool (chair, current); Charles J. Casamento (member, current); Fabiana Fedeli (member, current); John Glasspool (chair, unknown); Charles J. Casamento (member, unknown); Fabiana Fedeli (member, unknown). committee_id=alpha:committee:relmada-therapeutics-inc:nominating-and-governance ## Executive leadership - Charles Ence: Chief Accounting and Compliance Officer. Status: current. claim_id=alpha:claim:company:025d90a8-f941-4960-9a33-3393bec9d167:leadership_role:9 - Maged Shenouda: Chief Financial Officer [CFO]. Status: current. claim_id=alpha:claim:company:025d90a8-f941-4960-9a33-3393bec9d167:leadership_role:10 - Paul Kelly: Chief Operating Officer and Director [COO]. Status: current. claim_id=alpha:claim:company:025d90a8-f941-4960-9a33-3393bec9d167:leadership_role:11 - Sergio Traversa: Chief Executive Officer, and Director [CEO]. Status: current. claim_id=alpha:claim:company:025d90a8-f941-4960-9a33-3393bec9d167:leadership_role:12 ## Governance events - EXECUTIVE_APPOINTED: Charles Ence executive of RELMADA THERAPEUTICS, INC., effective 2026-04-17. Effective: 2026-04-17. Detected: 2026-10-10T04:46:27.563543+00:00. event_id=alpha:event:transition:1ympfwk1uk9kiu - CFO_CHANGED: Maged Shenouda executive of RELMADA THERAPEUTICS, INC., effective 2026-04-17. Effective: 2026-04-17. Detected: 2026-10-10T04:46:27.563543+00:00. event_id=alpha:event:transition:xst4leed8qi2 - EXECUTIVE_APPOINTED: Paul Kelly executive of RELMADA THERAPEUTICS, INC., effective 2026-04-17. Effective: 2026-04-17. Detected: 2026-10-10T04:46:27.563543+00:00. event_id=alpha:event:transition:wppyot1gbzsql - CEO_CHANGED: Sergio Traversa executive of RELMADA THERAPEUTICS, INC., effective 2026-04-17. Effective: 2026-04-17. Detected: 2026-10-10T04:46:27.563543+00:00. event_id=alpha:event:transition:tn7yff20wyj5 - DIRECTOR_APPOINTED: Fabiana Fedeli seat on RELMADA THERAPEUTICS, INC., effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-10T04:46:27.563543+00:00. event_id=alpha:event:transition:19f82wda4j18j - COMMITTEE_CREATED: Audit · Chair; Compensation; Nominating and Governance committee of RELMADA THERAPEUTICS, INC., effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-10T04:46:27.563543+00:00. event_id=alpha:event:transition:1xsilx1yeu3zv - COMMITTEE_MEMBER_ADDED: Fabiana Fedeli member of Audit · Chair; Compensation; Nominating and Governance, effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-10T04:46:27.563543+00:00. event_id=alpha:event:transition:1ajjrjtxqlae1 - DIRECTOR_APPOINTED: John Glasspool seat on RELMADA THERAPEUTICS, INC., effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-10T04:46:27.563543+00:00. event_id=alpha:event:transition:5o9ag17ci937 - COMMITTEE_CREATED: Audit; Compensation; Nominating and Governance · Chair committee of RELMADA THERAPEUTICS, INC., effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-10T04:46:27.563543+00:00. event_id=alpha:event:transition:c6v9931eu3icf - COMMITTEE_MEMBER_ADDED: John Glasspool member of Audit; Compensation; Nominating and Governance · Chair, effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-10T04:46:27.563543+00:00. event_id=alpha:event:transition:ourln51f8kgwp - DIRECTOR_APPOINTED: Charles J. Casamento seat on RELMADA THERAPEUTICS, INC., effective 2015-01-01. Effective: 2015-01-01. Detected: 2026-10-10T04:46:27.563543+00:00. event_id=alpha:event:transition:1hhkqxh1ehe7ld - COMMITTEE_CREATED: Audit; Compensation; Nominating and Governance committee of RELMADA THERAPEUTICS, INC., effective 2015-01-01. Effective: 2015-01-01. Detected: 2026-10-10T04:46:27.563543+00:00. event_id=alpha:event:transition:1tb7ygt1mzm0rl - COMMITTEE_MEMBER_ADDED: Charles J. Casamento member of Audit; Compensation; Nominating and Governance, effective 2015-01-01. Effective: 2015-01-01. Detected: 2026-10-10T04:46:27.563543+00:00. event_id=alpha:event:transition:1umn4tvt10ymr - DIRECTOR_APPOINTED: Sergio Traversa seat on RELMADA THERAPEUTICS, INC., effective 2012-01-01. Effective: 2012-01-01. Detected: 2026-10-10T04:46:27.563543+00:00. event_id=alpha:event:transition:wg2b8l1pv4iyf ## Scoped resources - `alpha://company/relmada-therapeutics-inc` (contract): https://registry.alpha.ac/api/public/companies/relmada-therapeutics-inc?format=record - `alpha://company/relmada-therapeutics-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/relmada-therapeutics-inc?format=record§ion=identity - `alpha://company/relmada-therapeutics-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/relmada-therapeutics-inc?format=record§ion=corporate-structure - `alpha://company/relmada-therapeutics-inc/board` (contract): https://registry.alpha.ac/api/public/companies/relmada-therapeutics-inc?format=record§ion=board - `alpha://company/relmada-therapeutics-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/relmada-therapeutics-inc?format=record§ion=committees - `alpha://company/relmada-therapeutics-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/relmada-therapeutics-inc?format=record§ion=leadership - `alpha://company/relmada-therapeutics-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/relmada-therapeutics-inc?format=record§ion=ownership - `alpha://company/relmada-therapeutics-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/relmada-therapeutics-inc?format=record§ion=financials - `alpha://company/relmada-therapeutics-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/relmada-therapeutics-inc?format=record§ion=capital-structure - `alpha://company/relmada-therapeutics-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/relmada-therapeutics-inc?format=record§ion=compensation - `alpha://company/relmada-therapeutics-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/relmada-therapeutics-inc?format=record§ion=governance - `alpha://company/relmada-therapeutics-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/relmada-therapeutics-inc?format=record§ion=shareholder-governance - `alpha://company/relmada-therapeutics-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/relmada-therapeutics-inc?format=record§ion=audit - `alpha://company/relmada-therapeutics-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/relmada-therapeutics-inc?format=record§ion=legal - `alpha://company/relmada-therapeutics-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/relmada-therapeutics-inc?format=record§ion=risk - `alpha://company/relmada-therapeutics-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/relmada-therapeutics-inc?format=record§ion=cyber - `alpha://company/relmada-therapeutics-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/relmada-therapeutics-inc?format=record§ion=ai-governance - `alpha://company/relmada-therapeutics-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/relmada-therapeutics-inc?format=record§ion=agents - `alpha://company/relmada-therapeutics-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/relmada-therapeutics-inc?format=record§ion=ecosystem - `alpha://company/relmada-therapeutics-inc/events` (contract): https://registry.alpha.ac/api/public/companies/relmada-therapeutics-inc?format=record§ion=events - `alpha://company/relmada-therapeutics-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/relmada-therapeutics-inc?format=record§ion=relationships - `alpha://company/relmada-therapeutics-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/relmada-therapeutics-inc?format=record§ion=assessments - `alpha://company/relmada-therapeutics-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/relmada-therapeutics-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:025d90a8-f941-4960-9a33-3393bec9d167:committee_appointment:14: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:fabiana-fedeli","name":"Fabiana Fedeli"},"source_id":"board_seats"}` - Claim alpha:claim:company:025d90a8-f941-4960-9a33-3393bec9d167:committee_appointment:15: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:charles-j-casamento","name":"Charles J. Casamento"},"source_id":"board_seats"}` - Claim alpha:claim:company:025d90a8-f941-4960-9a33-3393bec9d167:committee_appointment:16: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:john-glasspool","name":"John Glasspool"},"source_id":"board_seats"}` - Claim alpha:claim:company:025d90a8-f941-4960-9a33-3393bec9d167:committee_appointment:18: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:charles-j-casamento","name":"Charles J. Casamento"},"source_id":"board_seats"}` - Claim alpha:claim:company:025d90a8-f941-4960-9a33-3393bec9d167:committee_appointment:19: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:fabiana-fedeli","name":"Fabiana Fedeli"},"source_id":"board_seats"}` - Claim alpha:claim:company:025d90a8-f941-4960-9a33-3393bec9d167:committee_appointment:20: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:john-glasspool","name":"John Glasspool"},"source_id":"board_seats"}` - Claim alpha:claim:company:025d90a8-f941-4960-9a33-3393bec9d167:committee_appointment:22: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"chair","person":{"alpha_id":"alpha:person:john-glasspool","name":"John Glasspool"},"source_id":"board_seats"}` - Claim alpha:claim:company:025d90a8-f941-4960-9a33-3393bec9d167:committee_appointment:23: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:charles-j-casamento","name":"Charles J. Casamento"},"source_id":"board_seats"}` - Claim alpha:claim:company:025d90a8-f941-4960-9a33-3393bec9d167:committee_appointment:24: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:fabiana-fedeli","name":"Fabiana Fedeli"},"source_id":"board_seats"}` ## Leadership - Charles J. Casamento: Director, Audit; Compensation; Nominating and Governance. Claim: alpha:claim:company:025d90a8-f941-4960-9a33-3393bec9d167:leadership_role:5. Valid from: 2015-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ee4f13f82b85021162d0a2b867ab41f47a3b33ff6772a74709f63420ae70b895. - Fabiana Fedeli: Director, Audit · Chair; Compensation; Nominating and Governance. Claim: alpha:claim:company:025d90a8-f941-4960-9a33-3393bec9d167:leadership_role:6. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ee4f13f82b85021162d0a2b867ab41f47a3b33ff6772a74709f63420ae70b895. - John Glasspool: Director, Audit; Compensation; Nominating and Governance · Chair. Claim: alpha:claim:company:025d90a8-f941-4960-9a33-3393bec9d167:leadership_role:7. Valid from: 2019-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ee4f13f82b85021162d0a2b867ab41f47a3b33ff6772a74709f63420ae70b895. - Sergio Traversa: Director. Claim: alpha:claim:company:025d90a8-f941-4960-9a33-3393bec9d167:leadership_role:8. Valid from: 2012-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ee4f13f82b85021162d0a2b867ab41f47a3b33ff6772a74709f63420ae70b895. - Charles Ence: Chief Accounting and Compliance Officer. Claim: alpha:claim:company:025d90a8-f941-4960-9a33-3393bec9d167:leadership_role:9. Valid from: 2026-04-17. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:da10177ac844caba4a7ef1adc8517579bb4f447c23e96a99b23e87d9745ab222. - Maged Shenouda: Chief Financial Officer. Claim: alpha:claim:company:025d90a8-f941-4960-9a33-3393bec9d167:leadership_role:10. Valid from: 2026-04-17. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:dd640bb3c5618fe2124057cc303ea5743926d4c5c17312f35d8d833b97db09fa. - Paul Kelly: Chief Operating Officer and Director. Claim: alpha:claim:company:025d90a8-f941-4960-9a33-3393bec9d167:leadership_role:11. Valid from: 2026-04-17. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9e778f6380b0cfe1a78b89f06f2795aa611d6032b15bc830298cbc9784ac5727. - Sergio Traversa: Chief Executive Officer, and Director. Claim: alpha:claim:company:025d90a8-f941-4960-9a33-3393bec9d167:leadership_role:12. Valid from: 2026-04-17. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:83d65013329955c9526ec0a0893e4c83a77ef3aea7752566cf680d06c82a2711. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Audit: Chair Fabiana Fedeli; Members Fabiana Fedeli (Chair); Charles J. Casamento; John Glasspool. Claim: alpha:claim:company:025d90a8-f941-4960-9a33-3393bec9d167:committee_record:13. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:dbf5295b6ccc78121b3ae79e769f25f7a5316d254f35e56be28f3df8cd346e15. - Compensation: Chair not stated; Members Charles J. Casamento; Fabiana Fedeli; John Glasspool. Claim: alpha:claim:company:025d90a8-f941-4960-9a33-3393bec9d167:committee_record:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:dbf5295b6ccc78121b3ae79e769f25f7a5316d254f35e56be28f3df8cd346e15. - Nominating and Governance: Chair John Glasspool; Members John Glasspool (Chair); Charles J. Casamento; Fabiana Fedeli. Claim: alpha:claim:company:025d90a8-f941-4960-9a33-3393bec9d167:committee_record:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:dbf5295b6ccc78121b3ae79e769f25f7a5316d254f35e56be28f3df8cd346e15. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - RELMADA THERAPEUTICS, INC.. Claim: alpha:claim:company:025d90a8-f941-4960-9a33-3393bec9d167:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e98c1946f09a143210efcd928f166964fffb29f10776c3166763d9540ad528d9. ## Entity Status - Public listing published. Claim: alpha:claim:company:025d90a8-f941-4960-9a33-3393bec9d167:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e98c1946f09a143210efcd928f166964fffb29f10776c3166763d9540ad528d9. ## Published Fact - US. Claim: alpha:claim:company:025d90a8-f941-4960-9a33-3393bec9d167:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e98c1946f09a143210efcd928f166964fffb29f10776c3166763d9540ad528d9. ## Committee Appointment - Fabiana Fedeli: chair, Audit. Claim: alpha:claim:company:025d90a8-f941-4960-9a33-3393bec9d167:committee_appointment:14. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:dbf5295b6ccc78121b3ae79e769f25f7a5316d254f35e56be28f3df8cd346e15. - Charles J. Casamento: member, Audit. Claim: alpha:claim:company:025d90a8-f941-4960-9a33-3393bec9d167:committee_appointment:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:dbf5295b6ccc78121b3ae79e769f25f7a5316d254f35e56be28f3df8cd346e15. - John Glasspool: member, Audit. Claim: alpha:claim:company:025d90a8-f941-4960-9a33-3393bec9d167:committee_appointment:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:dbf5295b6ccc78121b3ae79e769f25f7a5316d254f35e56be28f3df8cd346e15. - Charles J. Casamento: member, Compensation. Claim: alpha:claim:company:025d90a8-f941-4960-9a33-3393bec9d167:committee_appointment:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:dbf5295b6ccc78121b3ae79e769f25f7a5316d254f35e56be28f3df8cd346e15. - Fabiana Fedeli: member, Compensation. Claim: alpha:claim:company:025d90a8-f941-4960-9a33-3393bec9d167:committee_appointment:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:dbf5295b6ccc78121b3ae79e769f25f7a5316d254f35e56be28f3df8cd346e15. - John Glasspool: member, Compensation. Claim: alpha:claim:company:025d90a8-f941-4960-9a33-3393bec9d167:committee_appointment:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:dbf5295b6ccc78121b3ae79e769f25f7a5316d254f35e56be28f3df8cd346e15. - John Glasspool: chair, Nominating and Governance. Claim: alpha:claim:company:025d90a8-f941-4960-9a33-3393bec9d167:committee_appointment:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:dbf5295b6ccc78121b3ae79e769f25f7a5316d254f35e56be28f3df8cd346e15. - Charles J. Casamento: member, Nominating and Governance. Claim: alpha:claim:company:025d90a8-f941-4960-9a33-3393bec9d167:committee_appointment:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:dbf5295b6ccc78121b3ae79e769f25f7a5316d254f35e56be28f3df8cd346e15. - Fabiana Fedeli: member, Nominating and Governance. Claim: alpha:claim:company:025d90a8-f941-4960-9a33-3393bec9d167:committee_appointment:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:dbf5295b6ccc78121b3ae79e769f25f7a5316d254f35e56be28f3df8cd346e15. ## Security Listing - RLMD (NASDAQ). Claim: alpha:claim:company:025d90a8-f941-4960-9a33-3393bec9d167:security_listing:25. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e98c1946f09a143210efcd928f166964fffb29f10776c3166763d9540ad528d9. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:e98c1946f09a143210efcd928f166964fffb29f10776c3166763d9540ad528d9: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/relmada-therapeutics-inc). - alpha:projection-evidence:document:ee4f13f82b85021162d0a2b867ab41f47a3b33ff6772a74709f63420ae70b895: [RELMADA THERAPEUTICS, INC. DEF 14A 2026-04-17](https://www.sec.gov/Archives/edgar/data/1553643/000121390026045192/ea0273288-03.htm). - alpha:projection-evidence:document:da10177ac844caba4a7ef1adc8517579bb4f447c23e96a99b23e87d9745ab222: [RLMD DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1553643/000121390026045192/ea0273288-03.htm). - alpha:projection-evidence:document:dd640bb3c5618fe2124057cc303ea5743926d4c5c17312f35d8d833b97db09fa: [RLMD DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1553643/000121390026045192/ea0273288-03.htm). - alpha:projection-evidence:document:9e778f6380b0cfe1a78b89f06f2795aa611d6032b15bc830298cbc9784ac5727: [RLMD DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1553643/000121390026045192/ea0273288-03.htm). - alpha:projection-evidence:document:83d65013329955c9526ec0a0893e4c83a77ef3aea7752566cf680d06c82a2711: [RLMD DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1553643/000121390026045192/ea0273288-03.htm). - alpha:projection-evidence:dbf5295b6ccc78121b3ae79e769f25f7a5316d254f35e56be28f3df8cd346e15: [Audit](https://www.sec.gov/Archives/edgar/data/1553643/000121390026045192/ea0273288-03.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/relmada-therapeutics-inc) - [Public Markdown](https://registry.alpha.ac/companies/relmada-therapeutics-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/relmada-therapeutics-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/relmada-therapeutics-inc?format=jsonld) - MCP resource: `alpha://companies/relmada-therapeutics-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-10T07:12:00.893079+00:00; recorded 2026-10-10T07:12:00.893079+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.